CUSHING'S SYNDROME
Clinical trials for CUSHING'S SYNDROME explained in plain language.
Never miss a new study
Get alerted when new CUSHING'S SYNDROME trials appear
Sign up with your email to follow new studies for CUSHING'S SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New scans hunt hidden hormone tumors
Diagnosis Recruiting nowThis study aims to find better ways to locate the small, hard-to-find tumors that cause a rare form of Cushing syndrome. Researchers will test two new types of PET scans (called F-DOPA and 68Ga-DOTATATE) in up to 80 patients to see which scan, or combination of scans, is most acc…
Matched conditions: CUSHING'S SYNDROME
Phase: PHASE2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Diagnosis
Last updated Apr 01, 2026 14:42 UTC
-
New scan aims to pinpoint elusive cause of hormone disorder
Diagnosis Recruiting nowThis study is testing a new type of PET scan to help doctors better diagnose and locate the source of Cushing's syndrome, a condition caused by too much of the stress hormone cortisol. Researchers will see if this scan, which targets a specific protein, is better than current met…
Matched conditions: CUSHING'S SYNDROME
Phase: PHASE1, PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Diagnosis
Last updated Mar 30, 2026 14:34 UTC
-
New scan aims to pinpoint rogue Hormone-Producing tumors
Diagnosis Recruiting nowThis study is testing a new radioactive tracer called [68Ga]Ga-PentixaFor to see if it can make PET scans better at identifying adrenal tumors that are overproducing hormones. Researchers will give the tracer to 80 adults with conditions like hyperaldosteronism or Cushing's syndr…
Matched conditions: CUSHING'S SYNDROME
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Diagnosis
Last updated Mar 11, 2026 14:54 UTC